Amphotericin B derivative blocks human immunodeficiency virus type 1 entry after CD4 binding: effect on virus-cell fusion but not on cell-cell fusion.

Documenti analoghi

• Possible role of the V3 domain of gp120 in resistance to an amphotericin B derivative (MS8209) blocking human immunodeficiency virus entry.
  di: Pleskoff, O, et al.
  Pubblicazione: (1996)
• Resistance to a drug blocking human immunodeficiency virus type 1 entry (RPR103611) is conferred by mutations in gp41.
  di: Labrosse, B, et al.
  Pubblicazione: (1997)
• Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells.
  di: Mayaux, J F, et al.
  Pubblicazione: (1994)
• Human immunodeficiency virus strains differ in their ability to infect CD4+ cells expressing the rat homolog of CXCR-4 (fusin).
  di: Pleskoff, O, et al.
  Pubblicazione: (1997)
• Complementation of murine cells for human immunodeficiency virus envelope/CD4-mediated fusion in human/murine heterokaryons.
  di: Dragic, T, et al.
  Pubblicazione: (1992)